{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T03:31:14Z","timestamp":1790220674568,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"DOI":"10.1038\/s41390-026-04826-7","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T14:35:07Z","timestamp":1771598107000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Live biotherapeutic product IBP-9414 (L. reuteri) in very low birth weight infants: the Connection Study"],"prefix":"10.1038","author":[{"given":"Josef","family":"Neu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Del Moral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott O.","family":"Guthrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark L.","family":"Hudak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Indrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Kronstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilia R.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neena","family":"Modi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Rastad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Schnitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachana","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Staffan","family":"Str\u00f6mberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hania","family":"Szajewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Thuresson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Caplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,20]]},"reference":[{"key":"4826_CR1","doi-asserted-by":"publisher","first-page":"e2023064153","DOI":"10.1542\/peds.2023-064153","volume":"153","author":"JD Horbar","year":"2024","unstructured":"Horbar, J. D. et al. Trends in mortality and morbidities for infants born 24 to 28 weeks in the US: 1997-2021. Pediatrics 153, e2023064153 (2024).","journal-title":"Pediatrics"},{"key":"4826_CR2","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1001\/jama.2021.23580","volume":"327","author":"EF Bell","year":"2022","unstructured":"Bell, E. F. et al. Mortality, in-hospital morbidity, care practices, and 2-year outcomes for extremely preterm infants in the US, 2013-2018. JAMA 327, 248\u2013263 (2022).","journal-title":"JAMA"},{"key":"4826_CR3","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1097\/QCO.0000000000000269","volume":"29","author":"ND Embleton","year":"2016","unstructured":"Embleton, N. D., Zalewski, S. & Berrington, J. E. Probiotics for prevention of necrotizing enterocolitis and sepsis in preterm infants. Curr. Opin. Infect. Dis. 29, 256\u2013261 (2016).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"4826_CR4","volume":"10","author":"S Sharif","year":"2020","unstructured":"Sharif, S., Meader, N., Oddie, S. J., Rojas-Reyes, M. X. & McGuire, W. Probiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants. Cochrane Database Syst. Rev. 10, CD005496 (2023).","journal-title":"Cochrane Database Syst. Rev."},{"key":"4826_CR5","doi-asserted-by":"publisher","first-page":"749","DOI":"10.3945\/an.116.014605","volume":"8","author":"J Sun","year":"2017","unstructured":"Sun, J. et al. Effects of probiotics on necrotizing enterocolitis, sepsis, intraventricular hemorrhage, mortality, length of hospital stay, and weight gain in very preterm infants: a meta-analysis. Adv. Nutr. 8, 749\u2013763 (2017).","journal-title":"Adv. Nutr."},{"key":"4826_CR6","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/s41372-024-01952-0","volume":"44","author":"SJ Wala","year":"2024","unstructured":"Wala, S. J. et al. Contemporary Use of Prophylactic Probiotics in NICUs in the United States: A Survey Update. J. Perinatol. 44, 739\u2013744 (2024).","journal-title":"J. Perinatol."},{"key":"4826_CR7","unstructured":"FDA Raises Concerns About Probiotic Products Sold for Use in Hospitalized Preterm Infants, https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-raises-concerns-about-probiotic-products-sold-use-hospitalized-preterm-infants (2023)."},{"key":"4826_CR8","unstructured":"Use of Probiotics in Preterm Infants, https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/medeffect-canada\/health-product-infowatch\/october-2023.html#a3_1a (2023)."},{"key":"4826_CR9","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1038\/s12276-020-0437-6","volume":"52","author":"M Cordaillat-Simmons","year":"2020","unstructured":"Cordaillat-Simmons, M., Rouanet, A. & Pot, B. Live biotherapeutic products: the importance of a defined regulatory framework. Exp. Mol. Med 52, 1397\u20131406 (2020).","journal-title":"Exp. Mol. Med"},{"key":"4826_CR10","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1002\/jpn3.12204","volume":"78","author":"CHP van den Akker","year":"2024","unstructured":"van den Akker, C. H. P. et al. Reevaluating the FDA\u2019s warning against the use of probiotics in preterm neonates: a societal statement by ESPGHAN and EFCNI. J. Pediatr. Gastroenterol. Nutr. 78, 1403\u20131408 (2024).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"4826_CR11","unstructured":"IBP-9414 for the Prevention of Necrotizing Enterocolitis - the Connection Study, https:\/\/clinicaltrials.gov\/study\/NCT03978000 (2019)."},{"key":"4826_CR12","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1055\/s-0044-1788275","volume":"42","author":"J Neu","year":"2025","unstructured":"Neu, J. et al. Clinical characteristics of necrotizing enterocolitis diagnosed by independent adjudication of abdominal radiographs, laparotomy, or autopsy in preterm infants in the \u201cConnection Trial\u201d. Am. J. Perinatol. 42, 268\u2013280 (2025).","journal-title":"Am. J. Perinatol."},{"key":"4826_CR13","doi-asserted-by":"publisher","first-page":"e2717","DOI":"10.1055\/s-0043-1774314","volume":"41","author":"J Neu","year":"2024","unstructured":"Neu, J. et al. Progression of enteral feeding volumes in extremely low birth weight infants in the \u201cConnection Trial. Am. J. Perinatol. 41, e2717\u2013e2726 (2024).","journal-title":"Am. J. Perinatol."},{"key":"4826_CR14","doi-asserted-by":"crossref","unstructured":"Guthrie S. O. et al. Association of clinical events to the time to a strict definition of sustained feeding tolerance in premature infants in the \u00b4Connection Trial\u2019. Br. J. Gastroenterol. 4, 264\u2013272 (2022).","DOI":"10.31488\/bjg.1000134"},{"key":"4826_CR15","doi-asserted-by":"crossref","unstructured":"Neu J. et al. Clinical outcomes correlating to a one-day shift in sustained feeding tolerance in very low birth weight infants in the \u2018Connection Trial\u2019. Br. J. Gastroenterol. 4, 255\u2013260 (2022).","DOI":"10.31488\/bjg.1000132"},{"key":"4826_CR16","unstructured":"Altman D. G. Practical Statistics for Medical Research (Chapman and Hall\/CRC, 1991)."},{"key":"4826_CR17","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s00281-020-00803-2","volume":"42","author":"A Humberg","year":"2020","unstructured":"Humberg, A. et al. Preterm birth and sustained inflammation: consequences for the neonate. Semin Immunopathol. 42, 451\u2013468 (2020).","journal-title":"Semin Immunopathol."},{"key":"4826_CR18","doi-asserted-by":"crossref","unstructured":"Duess, J. W. et al. Necrotizing Enterocolitis, Gut Microbes, and Sepsis. Gut Microbes, (2023).","DOI":"10.1080\/19490976.2023.2221470"},{"key":"4826_CR19","doi-asserted-by":"publisher","first-page":"e0132924","DOI":"10.1371\/journal.pone.0132924","volume":"10","author":"Y Konnikova","year":"2015","unstructured":"Konnikova, Y. et al. Late enteral feedings are associated with intestinal inflammation and adverse neonatal outcomes. PLoS One 10, e0132924 (2015).","journal-title":"PLoS One"},{"key":"4826_CR20","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3109\/15513815.2012.721477","volume":"32","author":"CR Martin","year":"2013","unstructured":"Martin, C. R. et al. Systemic inflammation associated with severe intestinal injury in extremely low gestational age newborns. Fetal Pediatr. Pathol. 32, 222\u2013234 (2013).","journal-title":"Fetal Pediatr. Pathol."},{"key":"4826_CR21","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.stem.2024.03.001","volume":"4","author":"AA Epstein","year":"2024","unstructured":"Epstein, A. A. et al. Injury to the subventricular zone stem cell niche is associated with intestinal perforation in preterm infants and predicts future motor impairment. Cell Stem Cell 4, 467\u2013483.e6 (2024).","journal-title":"Cell Stem Cell"},{"key":"4826_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-020-02304-5","volume":"20","author":"FS Wang","year":"2020","unstructured":"Wang, F. S. et al. Intestinal tract and parenteral multi-organ sequential pathological injury caused by necrotizing Enterocolitis. BMC Pediatrics 20, 418 (2020).","journal-title":"BMC Pediatrics"},{"key":"4826_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1254198","volume":"13","author":"Y Peng","year":"2023","unstructured":"Peng, Y. et al. Lactobacillus Reuteri in digestive system diseases: focus on clinical trials and mechanisms. Front Cell Infect. Microbiol 13, 1254198 (2023).","journal-title":"Front Cell Infect. Microbiol"},{"key":"4826_CR24","unstructured":"Birthweight and Gestation, https:\/\/www.cdc.gov\/nchs\/fastats\/birthweight.htm#:~:text=Number%20of%20babies%20born%20low,Percent%20born%20preterm:%2010.41%25 (2023)."},{"key":"4826_CR25","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/jpen.2564","volume":"47","author":"JL Ang","year":"2023","unstructured":"Ang, J. L., Athalye-Jape, G., Rao, S., Bulsara, M. & Patole, S. Limosilactobacillus Reuteri DSM 17938 as a probiotic in preterm infants: an updated systematic review with meta-analysis and trial sequential analysis. J. Parenter. Enter. Nutr. 47, 963\u2013981 (2023).","journal-title":"J. Parenter. Enter. Nutr."},{"key":"4826_CR26","doi-asserted-by":"publisher","unstructured":"Alshaikh, B. N. et al. Effectiveness and Risks of Probiotics in Preterm Infants. Lid - E2024069102 [Pii] Lid - https:\/\/doi.org\/10.1542\/Peds.2024-069102 [Doi].","DOI":"10.1542\/Peds.2024-069102"},{"key":"4826_CR27","unstructured":"IBT is granted breakthrough therapy designation for its drug candidate, https:\/\/ibtherapeutics.com\/press-releases\/ibt-is-granted-breakthrough-therapy-designation-for-its-drug-candidate\/ (2025)."},{"key":"4826_CR28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41390-020-1074-4","volume":"88","author":"RM Patel","year":"2020","unstructured":"Patel, R. M., Ferguson, J., McElroy, S. J., Khashu, M. & Caplan, M. S. Defining necrotizing enterocolitis: current difficulties and future opportunities. Pediatr. Res. 88, 10\u201315 (2020).","journal-title":"Pediatr. Res."},{"key":"4826_CR29","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/s41390-021-01687-0","volume":"91","author":"CR Martin","year":"2022","unstructured":"Martin, C. R. Definitions of necrotizing enterocolitis: what are we defining and is machine learning the answer? Pediatr. Res 91, 488\u2013489 (2022).","journal-title":"Pediatr. Res"},{"key":"4826_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpedsurg.2024.06.017","volume":"59","author":"G Dantes","year":"2024","unstructured":"Dantes, G. et al. Clinical predictors of spontaneous intestinal perforation vs necrotizing enterocolitis in extremely and very low birth weight neonates. J. Pediatr. Surg. 59, 161608 (2024).","journal-title":"J. Pediatr. Surg."},{"key":"4826_CR31","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.clp.2022.07.005","volume":"49","author":"LA Rausch","year":"2022","unstructured":"Rausch, L. A., Hanna, D. N., Patel, A. & Blakely, M. L. Review of necrotizing enterocolitis and spontaneous intestinal perforation clinical presentation, treatment, and outcomes. Clin. Perinatol. 49, 955\u2013964 (2022).","journal-title":"Clin. Perinatol."},{"key":"4826_CR32","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1177\/000992289903801102","volume":"38","author":"VK Rehan","year":"1999","unstructured":"Rehan, V. K. et al. Observer variability in interpretation of abdominal radiographs of infants with suspected necrotizing Enterocolitis. Clin. Pediatr. 38, 637\u2013643 (1999).","journal-title":"Clin. Pediatr."},{"key":"4826_CR33","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.clp.2012.12.003","volume":"40","author":"SC Amin","year":"2013","unstructured":"Amin, S. C., Pappas, C., Iyengar, H. & Maheshwari, A. Short Bowel Syndrome in the NICU. Clin. Perinat. 40, 53\u201368 (2013).","journal-title":"Clin. Perinat."},{"key":"4826_CR34","doi-asserted-by":"publisher","first-page":"e1190","DOI":"10.1542\/peds.2014-1058","volume":"135","author":"A Stey","year":"2015","unstructured":"Stey, A. et al. Outcomes and costs of surgical treatments of necrotizing Enterocolitis. Pediatrics 135, e1190\u2013e1197 (2015).","journal-title":"Pediatrics"},{"key":"4826_CR35","doi-asserted-by":"publisher","first-page":"915","DOI":"10.3390\/microorganisms9050915","volume":"9","author":"JE Spreckels","year":"2021","unstructured":"Spreckels, J. E. et al. Lactobacillus Reuteri colonisation of extremely preterm infants in a randomised placebo-controlled trial. Microorganisms 9, 915 (2021).","journal-title":"Microorganisms"},{"key":"4826_CR36","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack, F. P. et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 Vaccine. NEJM 383, 2603\u20133615 (2020).","journal-title":"NEJM"},{"key":"4826_CR37","doi-asserted-by":"crossref","unstructured":"Randomised Trial of Cholesterol Lowering in 4444 Patients with Coronary Heart Disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 344, 1383\u20131389 https:\/\/pubmed.ncbi.nlm.nih.gov\/7968073\/ (1994).","DOI":"10.1016\/S0140-6736(94)90566-5"},{"key":"4826_CR38","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1056\/NEJMoa1403489","volume":"372","author":"RM Patel","year":"2015","unstructured":"Patel, R. M. et al. Causes and timing of death in extremely premature infants from 2000 through 2011. NEJM 372, 331\u2013340 (2015).","journal-title":"NEJM"},{"key":"4826_CR39","unstructured":"Neu J. et al. https:\/\/ibtherapeutics.com\/wp-content\/uploads\/2016\/03\/Hot-topics-poster-1128.pdf (2016)."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-04826-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-04826-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-04826-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T05:52:27Z","timestamp":1775109147000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-026-04826-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":39,"alternative-id":["4826"],"URL":"https:\/\/doi.org\/10.1038\/s41390-026-04826-7","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,20]]},"assertion":[{"value":"22 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Table 1 of the supplementary file had been missing and has now been added.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Josef Neu reports funding from Infant Bacterial Therapeutics for the Principal Investigator role provided to the University of Florida, Mead Johnson for speaker bureau, personal honorarium, Abbott Laboratories for expert witness testimony, personal payment, IPOKRaTES Foundation for speaker travel costs, personal payment, Nestle Nutrition Institute and Medela for Global Scientific Advisory Board, personal payment. Teresa Del Moral reports funding from Infant Bacterial Therapeutics for the Principal Investigator role, institutional payment, and Advisory Board, personal payment. Scott O. Guthrie reports funding from ONY BioTech and Infant Bacterial Therapeutics for consultancy, personal payment, National Association of Neonatal Nurses 2024 Conference, and Academy of Neonatal Nursing 2024 Conference honoraria for speaking at the conference. Mark L. Hudak reports funding from Aerogen for a clinical trial provided to the University of Florida (completed), Infant Bacterial Therapeutics for clinical trials provided to the University of Florida (completed), NIH for clinical studies provided to the University of Florida, UpToDate for annual stipend for review of two articles, Infant Bacterial Therapeutics and Aerogen for consultancy, personal payment, NIH DIVA study for Chair of the DSMB Chair, Northeast Florida Healthy Start Coalition Voluntary participation, unfunded. Flavia Indrio reports funding from Infant Bacterial Therapeutics for consultancy, personal payment, Danone Nestle Nutrition Institute, and BioGaia for speaker fees, personal payment. Jae H. Kim reports funding from Fresenius-Kabi for an industry-sponsored research study, payment to institution, UpToDate for authorship of articles, personal payment, Infant Bacterial Therapeutics and Medela for Advisory Board, personal payment, Carag for consultant work, personal payment, Mother\u2019s Milk is Best for clinical advisory, personal payment, Medela for workshop speaker, personal payment, Medela for Attending Human Milk Institute Symposium, personal payment, FETO Trial at Cincinnati Children\u2019s for participation on a Data Safety Monitoring Board or Advisory Board, unpaid, NEC Society and UC Health Milk Bank Scientific Advisory Council, unpaid, Astarte Medical, Nicolette, and Innara Health personally owned stock\/stock options. Anders Kronstr\u00f6m is an employee of Infant Bacterial Therapeutics. Camilia R. Martin reports funding from Mead Johnson Nutrition, institutional payment, Baxter International and Infant Bacterial Therapeutics for consultancy, personal payment, Baxter International for speaker fees, personal payment, Winston & Strawn on behalf of Abbott Nutrition for expert testimony, personal payment, Plakous Therapeutics, LactaLogics, Vitara Biomedical, and Evive Biotech for advisory board, personal payment, NEC Society for Scientific Advisory Council, unpaid, Mead Johnson Nutrition for product support for active grant to institution. Neena Modi reports funding from Infant Bacterial Therapeutics consultancy (Advisory Board), personal payment. Jonas Rastad is an employee of Infant Bacterial Therapeutics. Thomas J. Schnitzer reports funding from Regeneron, Pfizer, Eli Lilly, Amgen, Taiwan Liposome Company, Novartis, Techfields, Paradigm, KolonTissueGene, GSK, and Vertex for grants\/contracts to Northwestern University, Pfizer, Lilly, IBSA, GSK, Tremeau, Moebius Medical, Paradigm, Techfields, AstraZeneca, and Infant Bacterial Therapeutics for consulting fees, personal payment, IQVIA, AstraZeneca, Alira Health, and Horizon Therapeutics for Data Safety Monitoring Board\/Advisory Board, personal payments. Rachana Singh reports funding from Infant Bacterial Therapeutics as the study sponsor, institutional payment, consulting fees, personal payment, Mead Johnson, and Abbott for expert testimony, and personal payment. Staffan Str\u00f6mberg is an employee of Infant Bacterial Therapeutics. Hania Szajewska reports funding from Ausnutria for Grant\/Funding, institutional payment, Winclove for financial donation to and study product support for the Medical University of Warsaw, Nestle Nutrition Institute, Nestle Health Science, and Danone\/Nutricia for consultancy, personal payment, Infant Bacterial Therapeutics for consultancy (Advisory Board), personal payment, Abbott, BioGaia, Biocodex, Danone\/Nutricia, Nestl\u00e9, NNI, Mead Johnson, and Novalac for speaker fees, personal payment, Nutricia Research Foundation for Advisory Board, personal payment, board member of the International Scientific Association for Probiotics and Prebiotics (ISAPP), unpaid. Marcus Thuresson is employed by Statisticon for which Infant Bacterial Therapeutics is a client. Michael Caplan reports funding from Infant Bacterial Therapeutics for the Advisory Board, personal payment.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The Investigator or his\/her representative explained the nature of the study to the legally authorized representative(s) (LAR) (parent or guardian) of the prospective infant participant, and answered all questions regarding this study, prior to obtaining informed consent. The Investigator obtained informed consent from the LAR(s) of each patient enrolled in the study, in accordance with the current version of the Good Clinical Practice guidelines and the laws and regulations of the country in which the investigation was being conducted.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent statement"}}]}}